Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group - Top-Institutions - MDSpire

Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group

  • By

  • Pietro Diana

  • Tobias Klatte

  • Daniele Amparore

  • Riccardo Bertolo

  • Umberto Carbonara

  • Selcuk Erdem

  • Alexandre Ingels

  • Onder Kara

  • Laura Marandino

  • Michele Marchioni

  • Stijn Muselaers

  • Nicola Pavan

  • Angela Pecoraro

  • Alessio Pecoraro

  • Eduard Roussel

  • Riccardo Campi

  • April 1, 2022

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Oncology
    • Cancer Research

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Urology
    • Oncology
    • Cancer Prevention

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Urology
    • Cancer Genomics

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Oncology
    • Imaging

  • #5

    European Association of Urology (EAU) Research Centers
    European Association of Urology (EAU) Research Centers

    Multiple cities, Europe

    Key Differentiators

    • Urology
    • Oncology
    • Epidemiology

Original Source(s)

Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group

  • by Pietro Diana, Tobias Klatte, Daniele Amparore, Riccardo Bertolo, Umberto Carbonara, Selcuk Erdem, Alexandre Ingels, Onder Kara, Laura Marandino, Michele Marchioni, Stijn Muselaers, Nicola Pavan, Angela Pecoraro, Alessio Pecoraro, Eduard Roussel, Riccardo Campi

  • April 1, 2022

Related Content

Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors: An Integrative Review

Sexual dysfunction is a lasting effect of treatment and can impact the quality of life of breast cancer survivors. This review examined the impact of different levels (none/low, moderate, and high) of physical activity on sexual outcomes in breast cancer survivors.

Patient Safety Events Among Children Receiving Home Health Care